Huntington's disease: ethical aspects of presymptomatic testing
Gelman-Kohan, Z.; Chemke, J.; Nisani, R.
Harefuah 124(4): 196-8 247
1993
ISSN/ISBN: 0017-7768 PMID: 8495897 Document Number: 405580
Huntington's disease is an autosomal dominant entity with onset mostly in middle age. Neurological signs and psychosis evolve without possibility of treatment or alleviation. Genetic counseling of relatives of patients has changed since the development of presymptomatic testing. Ethical issues and dilemmas associated with the application of this technological advances are reviewed as a result of a request by a mother to perform presymptomatic testing in her young daughter whose father has Huntington's disease.
Document emailed within 1 workday
Related Documents
Holloway, S.M.; Porteous, M.E.; Fitzpatrick, D.R.; Crosbie, A.E.; Cetnarskyj, R.; Warner, J.; Barron, L. 1998: Presymptomatic testing for Huntington's disease by linkage and by direct mutation analysis: comparison of uptake of testing and characteristics of test applicants Genetic Counseling 9(2): 103-111Walsh, A. 1999: Presymptomatic testing for Huntington's disease: the role of genetic counseling Medicine and Health Rhode Island 82(5): 168-170
Jacobs, H.; Latza, U.; Vieregge, A.; Vieregge, P. 2001: Attitudes of young patients with Parkinson's disease towards possible presymptomatic and prenatal genetic testing Genetic Counseling 12(1): 55-67
Roos, R.A.; Vegter-van der Vlis, M.; Tibben, A.; Skraastad, M.I.; Pearson, P.L. 1990: Procedure and initial results of presymptomatic DNA studies in Huntington's chorea Nederlands Tijdschrift Voor Geneeskunde 134(14): 704-707
Tibben, A.; Vegter-van der Vlis, M.; Roos, R.A.; van de Kamp, J.J.; Frets, P.G.; Verhage, F. 1990: Presymptomatic DNA diagnosis in Huntington's chorea: reactions to the certainty of not being a genetic carrier Nederlands Tijdschrift Voor Geneeskunde 134(14): 701-704
1997: Report of the Committee for the Study of Ethical Aspects of Human Reproduction. Some ethical issues in the doctor/patient relationship. Patenting of human genes. Ethical aspects in the management of newborn infants at the threshold of viability. The ethical aspects of sexual and reproductive rights. Cloning in human reproduction International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 59(2): 165-168
1997: Report of the Committee for the Study of Ethical Aspects of Human Reproduction. Some ethical issues in the doctor/patient relationship. Patenting of human genes. Ethical aspects in the management of newborn infants at the threshold of viability. The ethical aspects of sexual and reproductive rights. Cloning in human reproduction International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 59(2): 165-168
Andersson, K. 1990: Ethical questions on Huntington disease. Predictive tests--as to play Russian roulette Lakartidningen 87(50): 4290
Nukina, N. 1999: The function of Huntington disease gene product (huntingtin) and the pathomechanism of Huntington disease Nihon Rinsho. Japanese Journal of Clinical Medicine 57(4): 905-911
Alonso, M.E.; Nieto, D. 1985: Clinical and genetic aspects of Huntington's disease. Study of 28 patients Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 37(2): 125-130
Milliez, J. 2009: Ethical aspects concerning neonatal screening FIGO Committee for the Ethical Aspects of Human Reproduction and Women's Health International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 106(3): 273-274
Schenker, J.G. 1996: FIGO committee for the study of ethical aspects of human reproduction. Ethical aspects in the management of the severely malformed fetus. International Federation of Gynecology and Obstetrics Ginekologia Polska 67(11): 585-586
Klitzman, R.; Thorne, D.; Williamson, J.; Marder, K. 2007: The roles of family members, health care workers, and others in decision-making processes about genetic testing among individuals at risk for Huntington disease Genetics in Medicine: Official Journal of the American College of Medical Genetics 9(6): 358-371
Post, S.G.; Whitehouse, P.J.; Binstock, R.H.; Bird, T.D.; Eckert, S.K.; Farrer, L.A.; Fleck, L.M.; Gaines, A.D.; Juengst, E.T.; Karlinsky, H.; Miles, S.; Murray, T.H.; Quaid, K.A.; Relkin, N.R.; Roses, A.D.; St George-Hyslop, P.H.; Sachs, G.A.; Steinbock, B.; Truschke, E.F.; Zinn, A.B. 1997: The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective JAMA 277(10): 832-836
Cassel, C.K. 1998: Genetic testing and Alzheimer disease: ethical issues for providers and families Alzheimer Disease and Associated Disorders 12(Suppl 3): S16-S20
White, M.T.; Callif-Daley, F.; Donnelly, J. 1999: Genetic testing for disease susceptibility: social, ethical and legal issues for family physicians American Family Physician 60(3): 748 750 755 757-8
Kastelein, W.R. 1990: The predictive test in Huntington's chorea and the request not to be informed about results; an ethical problem with implications for the future Nederlands Tijdschrift Voor Geneeskunde 134(22): 1107-1108
2006: Ethical guidelines on sex selection for non-medical purposes. FIGO Committee for the Ethical Aspects of Human Reproduction and Women's Health International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 92(3): 329-330
Meiner, V.; Meiner, Z.; Reshef, A.; Björkhem, I.; Leitersdorf, E. 1994: Cerebrotendinous xanthomatosis: molecular diagnosis enables presymptomatic detection of a treatable disease Neurology 44(2): 288-290
Cain, J.M. 2002: Ethical guidelines regarding privacy and confidentiality in reproductive medicine. Testing for genetic predisposition to adult onset disease. Guidelines in emergency contraception International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 77(2): 171-175